TOTAVY Trademark

Trademark Overview

On Thursday, March 5, 2020, a trademark application was filed for TOTAVY with the United States Patent and Trademark Office. The USPTO has given the TOTAVY trademark a serial number of 88823360. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Monday, April 1, 2024. This trademark is owned by Gilead Sciences Ireland UC. The TOTAVY trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
totavy

General Information

Serial Number88823360
Word MarkTOTAVY
Filing DateThursday, March 5, 2020
Status686 - PUBLISHED FOR OPPOSITION
Status DateMonday, April 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 23, 2021

Trademark Statements

Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
Translation of Words in MarkThe wording "TOTAVY" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 11, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCARRIGTOHILL, CO. CORK
IE
Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCARRIGTOHILL, CO. CORK
IE

Trademark Events

Event DateEvent Description
Monday, April 1, 20241(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, March 13, 2024NOTICE OF ALLOWANCE CANCELLED
Wednesday, March 13, 2024TEAS DELETE 1(B) BASIS RECEIVED
Saturday, September 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 15, 2023SOU EXTENSION 5 GRANTED
Wednesday, September 6, 2023SOU EXTENSION 5 FILED
Friday, September 15, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 6, 2023SOU TEAS EXTENSION RECEIVED
Saturday, March 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 9, 2023SOU EXTENSION 4 GRANTED
Thursday, March 9, 2023SOU EXTENSION 4 FILED
Thursday, March 9, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 24, 2022SOU EXTENSION 3 GRANTED
Wednesday, August 24, 2022SOU EXTENSION 3 FILED
Wednesday, August 24, 2022SOU TEAS EXTENSION RECEIVED
Friday, March 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 16, 2022SOU EXTENSION 2 GRANTED
Wednesday, March 16, 2022SOU EXTENSION 2 FILED
Wednesday, March 16, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 10, 2021ASSIGNED TO EXAMINER
Saturday, August 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 19, 2021SOU EXTENSION 1 GRANTED
Thursday, August 19, 2021SOU EXTENSION 1 FILED
Thursday, August 19, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 20, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 23, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 14, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 14, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 8, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, September 20, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, September 20, 2020LETTER OF SUSPENSION E-MAILED
Sunday, September 20, 2020SUSPENSION LETTER WRITTEN
Wednesday, September 2, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 26, 2020ASSIGNED TO LIE
Thursday, August 6, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 28, 2020NON-FINAL ACTION E-MAILED
Thursday, May 28, 2020NON-FINAL ACTION WRITTEN
Sunday, May 24, 2020ASSIGNED TO EXAMINER
Wednesday, March 11, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 9, 2020NEW APPLICATION ENTERED

Related Keywords

totavy preparations pharmaceutical treatment disorders diseases anti respiratory autoimmune pulmonary kidney